Form 4: Teladoc Health Executive Nikolaos P. Nanis Reports Stock Transactions
SEC Form 4 Filing
Nikolaos P. Nanis, Chief Technology Officer of Teladoc Health, reports the acquisition and disposal of common stock and derivative securities related to performance stock units and restricted stock units.
Summary
- Nikolaos P. Nanis, the Chief Technology Officer of Teladoc Health, filed a Form 4 detailing changes in beneficial ownership.
- On May 31, 2024, Nanis acquired shares of common stock through the conversion of performance stock units and restricted stock units.
- Specifically, 370 shares were acquired from performance stock units, and 505, 894, and 1,085 shares were acquired from restricted stock units.
- On June 3, 2024, Nanis disposed of 1,040 shares of common stock at a price of $11.157 per share to cover tax withholding obligations.
- Following these transactions, Nanis directly owns 72,435 shares of Teladoc Health common stock.
- Nanis also holds derivative securities, including 2,588 performance stock units, 1,518 restricted stock units, 3,578 restricted stock units and 7,596 restricted stock units.
Sentiment
Score: 5
Explanation: This is a routine disclosure of stock transactions by a company executive. It doesn't inherently indicate positive or negative sentiment, but rather provides factual information.
Industry Context
Form 4 filings are routine disclosures required by the SEC to provide transparency into the transactions of company insiders, allowing investors to monitor management's alignment with shareholder interests.
Stakeholder Impact
- Shareholders can monitor the transactions of company insiders to assess management's alignment with their interests.
Key Dates
| Date | Description |
|---|---|
| 03/01/2022 | Reporting person was granted 6,064 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 06/01/2022 | Reporting person was granted 10,730 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/03/2023 | Reporting person was granted 13,021 restricted stock units, vesting one-third on the first anniversary of the grant date, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 03/01/2024 | Reporting person earned 4,437 performance stock units, vesting one-third on March 1, 2024, with the remainder vesting in eight substantially equal quarterly installments thereafter. |
| 05/31/2024 | Acquisition of common stock through conversion of performance stock units and restricted stock units. |
| 06/03/2024 | Sale of 1,040 shares of common stock to cover tax withholding obligations. |
| 06/04/2024 | Date of Form 4 signature. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.